Simcere Pharmaceutical (SCR): Q1 EPS of $0.08 in-line. Revenue of $77.4M (+5.2% Y/Y) misses by...

|About: Simcere Pharmaceutical G... (SCR)|By:, SA News Editor
Simcere Pharmaceutical (SCR): Q1 EPS of $0.08 in-line. Revenue of $77.4M (+5.2% Y/Y) misses by $7M. (PR)